Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 305 | 305 | 305 | 305 | 305 |
| Gross Profit | 305 | 305 | 305 | 305 | 305 |
| Operating Expenses | 14,147 | 13,482 | 11,446 | 15,543 | 8,939 |
| Operating Income | -13,842 | -13,177 | -11,141 | -15,238 | -8,634 |
| Other Income | 203 | 206 | 326 | 269 | 276 |
| Pre-tax Income | -13,639 | -12,971 | -10,815 | -14,969 | -8,358 |
| Net Income Continuous | -13,639 | -12,971 | -10,815 | -14,969 | -8,358 |
| Net Income | $-13,639 | $-12,971 | $-10,815 | $-14,969 | $-8,358 |
| EPS Basic Total Ops | -0.70 | -0.71 | 0.94 | -0.84 | -0.47 |
| EPS Basic Continuous Ops | -0.70 | -0.71 | 0.54 | -0.84 | -0.47 |
| EPS Diluted Total Ops | -0.70 | -0.71 | 0.94 | -0.84 | -0.47 |
| EPS Diluted Continuous Ops | -0.70 | -0.71 | 0.54 | -0.84 | -0.47 |
| EBITDA(a) | $-13,769 | $-13,171 | $-11,166 | $-15,307 | $-8,630 |